Author

Monalisa Mukherjee

Regional Centre for BiotechnologyORCID 0000-0002-7493-0409Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Kartiki Vasant DesaiiD· 1 shared Partha Das· 1 shared Saheli Pramanik· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Kartiki Vasant DesaiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 14, 2024

Suppression of miRs-497/195 axis possibly confers endocrine therapy resistance via elevated expression of FLT4 and the noncoding RNA MIR503HG

Saheli Pramanik, Partha Das, Monalisa Mukherjee, Kartiki Vasant Desai

The paper identifies miR-497/195 suppression as a mechanism of endocrine therapy resistance in breast cancer, linking it to elevated FLT4 and MIR503HG expression through RNA-seq and ceRNA network analysis.

DOI 10.1101/2024.05.14.594132

humanbulk RNA-seq

𝕏 PostBluesky